FDA Allows New Monkeypox Vaccination Method To Maximize Supply

The video discusses the limited supply of monkeypox vaccines and the FDA's authorization to change the administration method to intradermal, allowing more doses per vial. This decision comes after the Biden administration declared monkeypox a public health emergency. The new method is being implemented in Los Angeles County, increasing the number of vaccination sites. The CDC encourages people to get their second dose, as studies show similar immune responses with the reduced dose. Efforts are underway to open more vaccination facilities quickly.

What was the FDA's recent decision regarding the monkeypox vaccine aimed at addressing?

• Eliminating the need for a second dose

• Changing the vaccine formula

• Reducing the number of doses required

• Increasing the number of doses per vial

How is the new method of administering the monkeypox vaccine different from the previous method?

• It is given as a single dose instead of two

• It is administered as a nasal spray

• It is injected intradermally instead of subcutaneously

• It is given orally instead of intravenously

What is the benefit of the intradermal administration of the monkeypox vaccine?

• It speeds up the immune response

• It reduces side effects

• It eliminates the need for refrigeration

• It allows for more doses from a single vial

What does the CDC recommend for individuals who have delayed their second dose of the monkeypox vaccine?

• To switch to a different vaccine

• To wait for a new vaccine

• To skip the second dose

• To get the second dose as soon as possible

What did a 2015 clinical study reveal about the reduced dose of the monkeypox vaccine?

• It was less effective than the full dose

• It required additional booster shots

• It was ineffective in preventing the disease

• It provided a similar immune response as the full dose